G. . Gotto, “Real-world evidence in patient-reported outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate + prednisone (AA+P) across Canada: Final results of COSMiC”, CUAJ, vol. 14, no. 12, pp. E616–20, Jun. 2020.